# Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease

> **NCT00504803** · PHASE2 · COMPLETED · sponsor: **University of Liege** · enrollment: 30 (estimated)

## Conditions studied

- Hematological Malignancies

## Interventions

- **PROCEDURE:** Mesenchymal stem cell infusion

## Key facts

- **NCT ID:** NCT00504803
- **Lead sponsor:** University of Liege
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2011-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00504803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00504803, "Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00504803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*